SEARCH

SEARCH BY CITATION

Références

  • Adjuik M, Agnamey P, Babiker A et al. (2002) Amodiaquine-artesunate vs. amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359, 13651372.
  • Basco LK, Same-Ekobo A, Ngane VF et al. (2002) Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bulletin of the World Health Organization 80, 538545.
  • Delacollette C, Barutwanayo M & Mpitabakana P (1990) Epidémiologie du paludisme au Burundi. Observations préliminaires. Médecine d'Afrique Noire 37, 718723.
  • Dinis DV & Schapira A (1990) Comparative study of sulfadoxine-pyrimethamine and amodiaquine + sulfadoxine-pyrimethamine for the treatment of malaria caused by chloroquine-resistant Plasmodium falciparum in Maputo, Mozambique. Bulletin de la Société de Pathologie Exotique 83, 521527.
  • Dorsey G, Njama D, Kamya MR et al. (2002) Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 360, 20312038.
  • Ezzet F, van Vugt M, Nosten F, Looareesuwan S & White NJ (2000) Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrobial Agents Chemotherapy 44, 697704.
  • Hatz C, Abdulla S, Mull R et al. (1998) Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1–5 years. Tropical Medicine International Health 3, 498504.
  • Marimbu J, Ndayiragije A, Lebras M & Chaperon J (1993) Environment and malaria in Burundi. Apropos of a malaria epidemic in a non-endemic mountainous region. Bulletin de la Société de Pathologie Exotique 86, 399401.
  • Nosten F, van Vugt M, Price R et al. (2000) Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356, 297302.
  • Olliaro P, Nevill C, LeBras J et al. (1996) Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348, 11961201.
  • Schapira A & Schwalbach JF (1988) Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986. Bulletin of the World Health Organization 66, 219226.
  • Schellenberg D, Kahigwa E, Drakeley C et al. (2002) The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene 67, 1723.
  • von Seidlein L, Bojang K, Jones P et al. (1998) A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. American Journal of Tropical Medicine and Hygiene 58, 638644.
  • Sokhna CS, Trape JF & Robert V (2001) Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine. Parasite 8, 243250.
  • Sowunmi A (2002) A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology 96, 227238.
  • Van Vugt M, Wilairatana P, Gemperli B et al. (1999) Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene 60, 936942.
  • White NJ (1999) Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41, 301308.
  • WHO (2001a) Antimalarial drug combination therapy, report of a WHO technical consultation. WHO/CDS/RBM/2001.35.
  • WHO (2001b) Monitoring antimalarial drug resistance. WHO/CDS/CSR/EPH/2002.17.
  • WHO (2001c) The use of antimalarial drugs, report of a WHO informal consultation. WHO/CDS/RBM/2001.33.